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Erythroderma /exfoliative der ma ti tis/ is an in flam ma tory pro cess af fect ing 90% of the to tal body sur face
area. Er y thema, in fil tra tion and des qua ma tion are the main clin i cal fea tures of the syn drome. It ap pears in
the con text of many dermatological and sys temic dis or ders, as well as neo plas tic pro lif er a tion of ei ther skin or
in ter nal parenchymal or gans. Erythroderma is a life-threathening con di tion which re quires emer gent com -
plex mea sures. Herein a short over view of the clin i cal, pathogenetic, di ag nos tic and ther a peu tic
characteristics of the syndrome is presented.
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Erythroderma is an in flam ma tory pro cess that af fects more
than 90% of the to tal body sur face. The most char ac ter is tic
clin i cal featureste of the syn drome are er y thema, in fil tra tion 
and des qua ma tion. The term exfoliative der ma ti tis is used
in ter change ably with the clas sic Latin de scrip tion, while
cases of erythroderma in as so ci a tion with palmo-plan tar
keratoderma, dermopathic lymphadenopathy, and el e vated
lev els of im mu no glob u lin E (IgE) are de picted as “red man
syn drome” (Brady et al. 2000). The term l’homme rouge
re fers to exfoliative dermatitides that oc cur in the con text of 
pri mary T-cell lym pho mas, and most of ten man i fest with
erythro-livid infiltarion of intensive itch and bad prognosis
(Freedberg, 1987).
Clas si fi ca tion
Bazin (1866) made the first sci en tific at tempt to clas sify
erythrodermas as pri mary (id io pathic) and sec ond ary (that
oc cur in the course of pre-ex ist ing dermatosis). Wolters
(1912) de fined the ac quired forms as symp tom atic. In 1928
Darier spec i fied three groups of exfoliative dermatitides ac -
cord ing to their clin i cal course: acute, sub acute (Wil -
son-Brocq), and chronic (Wil son-Brocq, pityriasis rubra
Hebra-Jadassohn, pre-mycotic and leu ke mic). Degos
(1953) de scribed two clin i cal forms of erythroderma:
erythemo-squamous and vesiculo-bullous, and clas si fied
them as pri mary (der ma ti tis exfoliativa Wil son-Brocq è
pityriasis rubra Hebra), sec ond ary (pso ri a sis vulgaris, li -
chen ruber planus, ec zema, pityriasis rubra pilaris,
pemphigus foliaceus), drug-in duced (As, Bi, Hg), in fec -
tious, pre-mycotic, and leu ke mic. The first clinico-patho -
logic cor re la tion appraoch in the erythroderma clas si fi ca -
tion was made by Herzberg  in 1958. Ac cord ing to him,
five forms: pityriasis rubra Hebra-Jadassohn typev
(pityriasiform des qua ma tion, nail changes, and al o pe cia),
melanoerythroderma of the el derly, der ma ti tis exfoliativa
Wil son-Brocq type (lamellar ex fo li a tion,
lymphadenopathy, al o pe cia, and nail changes oc cur ring as
a com pli ca tion of con tact der ma ti tis, or pyogenic in fec -
tion), er y thema scarlatiniforme recidivans (drug-in duced
erythroderma), and vesiculo-bullous erythroderma with
toxic shock syndrome and bad prgnosis should be
distinguished.
The first Bul gar ian ob ser va tions on erythroderma ap peared 
in 1967 (Pophristov and  Zlatkov), who pub lished a broad
over view of 67 clin i cal cases and sum ma rized their 25-year 
ex pe ri ence into a pathogenetic at tempt for clas si fi ca tion.
Ac cord ing to these au thors the fol low ing types of
erythroderma ex ist: 1. exfoliative der ma ti tis oc cur ring in
the course of pre-ex ist ing dermatoses  (pso ri a sis vulgaris,
ec zema, pityriasis rubra pilaris, li chen ruber planus, etc.); 2.
erythroderma as a com pli ca tion of lymphoproliferative dis -
or der (pri mary T cell cu ta ne ous lym phoma, mycosis
fungoides, morbus Hodg kin, leukemias); 3. toxo-al ler gic
erythrodermas (drug-in duced); in fec tious types (bac te rial,
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Dermatoses
dermatitis/eczema (atopic, contact, seborrheic, stasis,
etc), psoriasis, pityriasis rubra pilaris, pemphigus
foliaceus, morbus Hailey-Hailey, pemphigoid, lichen
planus, lupus erythematosus, mycosis fungoides,
dermatophytosis, scabies, sarcoid, toxic shock syndrome
Systemic diseases
Lymphoma, leukemia, multiple myeloma, internal
organs carcinomas
Drugs
dimercaprol, codeine, captopril, diphenylhydantoin,
carbamazepine, hexaquine, aztreonam è clindamycin,
bevacizumab, enalapril, quinidine, minocycline,
isoniazid, beta lactames, gold salts, barbiturates, anti
psychotic drugs, C a antagonists, etc. 
Infectious
Bacterial SSSS, erythema scarlatiniformis recidivans
F ungal: C andidiasis
Protoz oic: S cabies
T ab le1 . A cq uired eryth roderma etiology
mycotic, vi ral, protozoal); 4. erythrodermas oc cur ring as a
com pli ca tion of a sys temic dis or der (hepatic, renal,
endocrine, etc.); 5. miscellaneous (idiopathic).
E ti ol og y
M a lig nant lympho-proliferative dis or ders, (K im et al,
2006), gas tro-in tes ti nal dys func tion (K ameyama et al.,
2005), nephrotic syn drome (K agan et al., 1999), di a be tes
mellitus (Bouwhuis et al., 2002), ad re nal, sex -
ual,pituaryvdisorders (Herzberg, 1958),
macroglobilinemias (S utton, 1956), in fec tions and in tox i -
ca tions (Duperrat, 1959),  iat ro genic rea sons (Degos, 1960) 
and al co hol abuse (Bader, 1999) are all sug gested as po ten -
tial cause for exfoliative dermatitis.
E p  i d e  m i ol og y  
Hasan and Jansen (1983) re ported an exfoliative der ma ti tis
U S  in ci dence of 1-2 /100 000, which in creased to 35/100
000 in the dermatologically af fected pop u la tion. The Dutch 
in ci dence is found lower 0.9/100 000 (S igurdsson, 2001),
how ever, the low est in ci dence is re ported out of Tu ni sia –
0.3/100 000 (R ym, 2005).  M en are more of ten af fected:
1.85 ( in Iran), 2.2 (in Tu ni sia), 2.3 (in Bul garia), 2.6 (in
S wit zer land –  Eugster, 2001) to 4 (in S pane,
Botella-Estrada, 1994). N o ra cial pre dis po si tion is re ported. 
The dis ease on set is in the four de cade of life, with a me -
dium on set age of  41.9 years (S ehgal, 1986) to 61 years
(Hasan, 1983). Botella-Estrada et al. (1994), Hasan et al.
(1983) and S ehgal et al. (1986) ob served slow, and grad ual
on set of the syn drome, with the ex cep tion of drug-in duced,
lym phoma, and staph y lo coc cal scalled skin syn drome
cases which dis sem i nated rap idly over no more than 48
hours. 33.3% of all erythrodermas be gin spon ta ne ously,
while the rest 66.7% re sult from the distribution of a
previously existing dermatosis.
The higher in ci dence of symp tom atic erythodermas that
oc cur in the con text of ma lig nan cies or se vere sys temic dis -
or ders re quires thor ough work-up of all pa tients, re gret ting
the his tory of a pre-ex ist ing dermatosis (Eugster et al.,
2001). M orar et al. (1999) de tected higher in ci dence of
exfoliative der ma ti tis in HIV-pos i tive pa tients, sug gest ing
this as a re sult of ei ther polypragmasia or dermatological
com pli ca tions. The au thors con cluded that ev ery
erythroderma in a black man  should be screened for HIV
in fec tion. Erythroderma is a life-threat en ing con di tion that
should be treated in a in ten sive care unit with all the pre req -
ui sites of a po ten tially le thal dis or der. 43% of all gen er al -
ized exfoliative der ma ti tis cases die. An ac cent should be
given to a state of fe ver which is found to be the most
sensitive negative prediction factor (Byer et Bachur, 2000).
P ath op h y siolog y
S igurdsson et al. (2000) de tected dysbalanced der mal
cytokine pro file in both in flam ma tory and neo plas tic
erythodermas. In ter feron gamma (IFN -gamma) is per sis -
tently in creased in all cases of id io pathic and atopic der ma -
ti tis rel e vant exfoliative dermatitides. The lym phoma cases
al ways dem on strate el e vated lev els of interleukin 4
(IL-4)-an ti gen pre sent ing cells. The der mal in flam ma tion
in the pri mary T-cell lym pho mas is con sid ered to be
ofvTh2 pro file, in con trast with the prev a lence of Th1
cytokines in the be nign forms of erythroderma. Fierro et al.
(2006) gave fur ther in sight of the pathogenesis of in flam -
ma tory exfoliative der ma ti tis dem on strat ing sig nif i cant in -
crease in C C R 5 and C X C R 3 in the lym pho cytes of der mal
tis sue sec tions. O b vi ously, the two main types of
erythroderma –  in flam ma tory and neo plas tic –  have been
caused by di a met ri cally op po site  immuno-patho log i cal
trends. The Th1 prev a lence in be nign erythroderma cases
may be a re sult of po ten ti ated vi ral in fec tion. M ore over,
Huang et al. (2006) proved sig nif i cant re ac ti va tion of hu -
man her pes virus 6 (HHV 6) in 35% of idiopathic
erythroderma cases to none in healthy controls (p< 0.001). 
H istolog ical find  ing s
The du ra tion and se ver ity of the in flam ma tory changes
rather than the pre-ex ist ing der ma tol ogy spe cific fea tures
are the most im por tant fac tors to in flu ence the
histomorphological sub strate (C o hen et al., 1997). The
acute stage char ac ter izes with spongiosis, parakeratosis,
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References Pre-existing dermatoses drug-induced malignancies idiopathic
Pophristov et al, 196 7 50 8.3 26.7 10
N icolis et Helwig, 197 3 25 42 21 12
Hasan et J ansan, 1983 42 22 4 32
Sehgal et Srivastava, 1986 52.2 24.7 0 22.5
King et al, 1986 30 34 20 16
Sigurdsson et al, 1996 53 5 13 26
Pal et Haroon,1998 74.4 5.5 5.5 14.6
Eugster et al.,  2001 58 16 11 15
T ab le 2 . A cq uired ex foliative dermatitis etiologic distrib ution
and mixed infammatory infitrate in the edem a tous pap il lary 
dermis. The  chronic his tol ogy changes en com pass
psoriasiform der ma ti tis fea tures with prom i nent acanthosis
and elon ga tion of rete ridges. The neo plas tic erythroderma
could show some pleomorphic in fil trate with or with out
obscuration of the  der mo-epi der mal junc tion and lichenoid 
in flam ma tion of atyp i cal cerebriform lym phoid cells with
epidermotropism and Putrier microabscess for ma tion
(S haikh å t R ahman, 2006). Al though un spe cific,
papillomatosis and con flu ent rete ridges could be signs of
pre-ex ist ing pso ri a sis. S u per fi cial acantholysis oc curs in
cases of pemphigus foliaceus and staphyloccocal scalded
skin syn drome (S criv ener et al., 1998). Ver ti cally and hor i -
zon tally al ter nat ing parakeratosis ver i fies pityriasis rubra
pilaris. Plen ti ful ness of eosinophils interstially and around
pap il lary vessels suggest drug-induced process or
hyperoesinophilic syndrome (Brady et al, 2000).
Clin i cal find  ing s
U n spe cific clin i cal find ings and low clinico-patho log i cal
cor re la tion are the most im por tant fea tures of erythroderma. 
Bî tella-Estrada et al. (1994) proved that only in 10% of all
pre-ex ist ing dermatosis erythroderma cases with out pre vi -
ous his tory, the spe cific clin i cal en tity could be ver i fied.
M ore over, the pro cess of ver i fi ca tion re quires se ries of his -
tol ogy and clin i cal ob ser va tions. Along with er y thema and
ex fo li a tion, which are oblig a tory,  Akhyani et al. (2005)
found that 97.5% of all cases with erythroderma had pru ri -
tus,  lymphadenopathy (21.3%), edema (14.4%),
hyperkeratosis (7.2%) and mucosal in volve ment (1%).
Pityriasiform des qua ma tion is seen in seborrheic and con -
tact der ma ti tis. Lamellar des qua ma tion oc curs in cases of
pemphigus foliaceus and  ma lig nant lympho-proliferative
skin dis or ders. The most in ten sive and ther apy-re sis tant
itch as so ci ates mycosis fungoides, li chen ruber planus, and
drug-in duced dermatoses, while the psoriatic erythroderma
is asymp tom atic. Dermatopathic lymphadenopathy is
characteriztic for eczematic states, li chen planus, and
drug-in duced cases, and does not ap pear in pso ri a sis and
pityriasis rubra pilaris. N ail dys tro phy and subungual
hyperkeratosis most of ten de velop in pityriasis rubra pilaris
and mycosis fungoides, in the clin i cal pic ture of the lat ter
cicatricial al o pe cia and  mucinosis follicularis are com -
monly seen. Pal and Haroon (1998) found out that mucosal
changes oc curred most fre quently in cases of li chen planus
and drug-in duced erythrodermas. Periorbital er y thema and
fine des qua ma tion is seen in con tact and atopic
dermatitides, and ectropion and epiphora are com mon
com pli ca tions.   Ac cord ing to R ook et al. (1987) liver and
spleen en large ment oc cur in mycosis fungoides, drug re ac -
tions and pityriasis rubra pilaris. In tact skin is lands could be 
seen both in pityriasis rubra pilari and psoriatic
erythroderma. O fuji papuloerythroderma fea tures the 
deck-chair sign and of ten has wheals flares (Pullmann et al., 
2004). M am mary gland pro lif er a tion, prob a bly due to sec -
ond ary hyperestrogenemia, could be a com pli ca tion of 
long-last ing, re frac tory erythroderma (S huster et Brown,
1962). Vomitus, fa tigue, faint ness, and fe ver are the most
com mon con sti tu tional symp toms of erythroderma. The
old age and met a bolic dis tur bances that com pli cate the
course of the dis ease, lead to car diac ar rest, pe riph eral cir -
cu la tory in suf fi ciency and throm botic in ci dences. The pa -
tients be come immunocompromised in the course of the
dis eases and com monly de velop skin, soft tis sue and
pulmonal in fec tions. Pneumonias are the most fre quent
cause for death in erythroderma patients.
D i ag  no sis
Verification is clin i cal.Ac cord ing to Walsh et al. (1994) the
mi cro scopic iden ti fi ca tion of spongiotic der ma ti tis, mycosis
fungoides and pso ri a sis as causes of erythroderma is eas ier
than that of drug-in duced exfoliative der ma ti tis and pityriasis
rubra pilaris. R e mark ably, the epidermotropism which is con -
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Ac quired erythroderma
Symptom Psoriasis L ichen planus
Pityriasis
rubra pilaris





Itch + + + + +
L ymphadenopathy + +





N ail lesions + +
Cicatricial alopecia + +
Deck chair sign +
Visceral involvement + + +
T ab le 3 . Specific clinical symptoms of pre-ex isting dermatosis eryth roderma 
sid ered the most im por tant sign of neo plas tic lym phoid pro lif -
er a tion has been proven to oc cur in other cases of lichenoid
der ma ti tis, such as drug-in duced or vi ral, there fore it should be 
re ferred to as a mis lead ing pathomorphological fea ture. S e rial
bi op sies and step sec tions are re quired to im prove the spec i fic -
ity of the histological ex am i na tion. R e cently, an at tempt for in -
tro duc ing new cy tol ogy ap proaches in the dis tinc tion of in -
flam ma tory and neo plas tic orgini of erythroderma is made.
Immunohistochemistry is re quired is cases of pleomorphic
lym phoid pro lif er a tions and lym phoma sus pi cion. How -
ever, in his large study of erythrodermic T-cell lym pho mas
and their be nign in flam ma tory sim u la tors, Vonderheid
(2006) de fined the immunohistochemistry ap proaches as
un re li able and non-specific.
First C ordel et al.  in 2001 in tro duced mo lec u lar-ge netic
meth ods in ver i fi ca tion of erythroderma di ag no sis. De tec -
tion of monoclonal lym phoid pro lif er a tion in the blood and
tis sue sec tions is of ut most sig nif i cance in the work-up of
erythrodermic lym phoma pa tients.  Vonderheid (2005)
sug gested that C D4+C D7- and C D4+C D26- phe no type of
pe riph eral T-lym pho cytes is char ac ter is tic for pri mary cu -
ta ne ous T-cell lym pho mas. Flow-cytometric de tec tion of
ab nor mal lym phoid pop u la tions in the pe riph eral blood of
pa tients with S ezary syn drome serves as highly sen si tive
and spe cific cri te rion for treat ment ef fi cacy and prog no sis.
(M orice et al., 2006). In con clu sion, the clin i cal,
histological, and flow-cytometric find ings are the most im -
por tant tools for dif fer en ti a tion of ma lig nant and be nign
exfoliative dermatitides. Immunohistochemistry and
molecular approaches could only further confirm and
specify the diagnosis.
T h e r  ap y
Erythroderma is a life-threat en ing con di tion that should be
treated in an in ten sive care unit. R ehydratation and pro tein ex -
pan sion is needed in ac cor dance with 24-hour diuresis and
edem a tous con di tions. M in i mal num ber of med i ca tions
should be in tro duced, since many of them could de te ri o rate or
cause drug-in duced erythroderma. Top i cal ther apy of emol -
lients, an ti sep tic baths, and cool dress ings is pref er a ble (R othe
et al., 2005). Pro tein-rich diet with fol ate supplementation
should be in tro duced. The anti-in flam ma tory and cat a bolic
na ture of corticosteroids make them a first-line ther apy
(Horiuchi, 2000). Etilogical treat ment should be con sid ered in
cases with a well-known his tory of a pre-ex ist ing dermatosis.
Bi o log i cal ther apy  has been proven ben e fi cial in psoriatic
erythroderma (Lewis et al., 2006). Daclizumab has been suc -
cess fully used in lympho-proliferative cu ta ne ous dis or ders
(O sborne et al., 2006). 
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